Clinical Trials Browser

Phase 2 × INDUSTRY × ranpirnase × Clear all

NCT01184287 2015-09-02

A Study Of Ranpirnase(Onconase®) To Pemetrexed Plus Carboplatin In Patients With Non-Squamous Non-Small Cell Lung Cancer

Phase 2 Withdrawn

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms